Atour Lifestyle (NASDAQ:ATAT – Get Free Report) posted its earnings results on Wednesday. The company reported $0.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.11, Zacks reports. The company had revenue of $407.74 million during the quarter, compared to the consensus estimate of $379.74 million. Atour Lifestyle had a net margin of 17.22% and a return on equity of 52.71%.
Here are the key takeaways from Atour Lifestyle’s conference call:
- Q1 revenue rose 47.5% year over year to RMB 2.81 billion, driven by strong growth in both managed hotels and the retail business. Adjusted EBITDA margin also improved to 25.5%, showing solid operating leverage.
- Hotel RevPAR returned to growth, with overall RevPAR at 102.4% of last year’s level, supported mainly by higher ADR. Management said Q2 RevPAR remains “cautiously optimistic” but still expects some market volatility.
- The company opened 110 new hotels in the quarter and ended with 2,088 hotels in operation, while the development pipeline remained healthy at 751 hotels. Management kept its full-year opening target unchanged and said hotel closure plans also remain unchanged.
- Retail revenue surged 54.4% to RMB 1.07 billion, and management raised its full-year retail revenue guidance to 30%–35% growth from the prior target. New product iterations, especially in bedding, were cited as a key driver of demand.
- The company highlighted strong shareholder returns, including its first 2026 cash dividend of about US$72 million and more than US$100 million of buybacks since last year. Management reiterated a goal of returning roughly 100% of prior-year GAAP net profit through dividends and repurchases.
Atour Lifestyle Price Performance
Atour Lifestyle stock opened at $36.97 on Friday. The stock has a market capitalization of $5.11 billion, a PE ratio of 19.88, a price-to-earnings-growth ratio of 0.91 and a beta of 0.72. The business has a 50 day simple moving average of $37.02 and a 200-day simple moving average of $38.51. Atour Lifestyle has a 12 month low of $28.97 and a 12 month high of $43.17.
Analyst Ratings Changes
Read Our Latest Stock Report on Atour Lifestyle
Institutional Investors Weigh In On Atour Lifestyle
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Mcguire Capital Advisors Inc. purchased a new position in Atour Lifestyle during the fourth quarter valued at $49,000. Invesco Ltd. lifted its stake in Atour Lifestyle by 74.3% in the 4th quarter. Invesco Ltd. now owns 130,850 shares of the company’s stock valued at $5,155,000 after buying an additional 55,790 shares in the last quarter. NewEdge Advisors LLC acquired a new stake in Atour Lifestyle in the 4th quarter worth about $84,000. Susquehanna Portfolio Strategies LLC purchased a new stake in Atour Lifestyle during the 4th quarter worth approximately $6,960,000. Finally, Numerai GP LLC raised its holdings in shares of Atour Lifestyle by 56.0% during the fourth quarter. Numerai GP LLC now owns 55,655 shares of the company’s stock valued at $2,193,000 after acquiring an additional 19,968 shares during the last quarter. Hedge funds and other institutional investors own 17.79% of the company’s stock.
About Atour Lifestyle
Atour Lifestyle Holdings Co, Ltd. operates as a hospitality and lifestyle company offering a range of lodging and accommodation services in China. The company’s core business includes the development, operation and management of boutique hotels and serviced apartments under its Atour Hotel and Ankora brands. These properties cater primarily to the mid- to upscale segment, delivering a blend of comfort, design-focused interiors and localized services tailored to both business and leisure travelers.
In addition to room offerings, Atour Lifestyle provides a suite of ancillary services designed to enhance guest experiences.
Featured Articles
- Five stocks we like better than Atour Lifestyle
- Karman: Defense Darling’s Outlook Strengthens After 40% Drop
- Aeluma’s Post-Earnings Dip Creates a Buying Opportunity
- Be Ready: 3 Upcoming Catalysts Could Drive Oracle to Record Highs
- 2 Ways to Play the Big Pharma Patent Cliff
Receive News & Ratings for Atour Lifestyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atour Lifestyle and related companies with MarketBeat.com's FREE daily email newsletter.
